Nivalis Therapeutics, Inc. NVLS
No live quote for NVLS yet.
- Market cap
- 37.58M
- P/E ratio
- -1.15
- Forward P/E
- -2.70
- Volume
- 25.38K
- Avg volume
- 48.43K
- Open
- 2.35
- Previous close
- 2.35
- Analysts
- Hold
No chart data for this range yet.
Key statistics
- Enterprise value
- 0
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 0.00%
- Free cash flow
- 0
- Total cash
- 0
- Total debt
- 0
- Return on equity
- 0.00%
- Short % of float
- 0.00%
- 50-day average
- 2.38
- 200-day average
- 2.50
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 28, 2016 | Raymond James | down | — | Market Perform |
| Nov 28, 2016 | Cowen & Co. | down | — | Market Perform |
| Nov 28, 2016 | Baird | down | — | Neutral |
| Nov 28, 2016 | Stifel Nicolaus | down | — | Hold |
| Sep 12, 2016 | Raymond James | init | — | Outperform |
| Jul 12, 2015 | Stifel Nicolaus | init | — | Buy |
News
15 Biggest Mid-Day Losers For Wednesday - 22 Stocks Moving In Wednesday's Pre-Market Session
Mid-Afternoon Market Update: Crude Oil Down 3.5%; Thor Industries Shares Surge On Earnings Beat 
Six Semiconductor Stocks Trading Near 52-Week Highs 
Novellus Earnings Preview: An Early Peek at Tech Earnings - Benzinga's Top ETF Gainers, February 25th (SOXL, TNA, DRN, BAL)
- Applied Grows but Solar Disappoints - Analyst Blog
Your note
Sign in to keep a note on NVLS — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BVF PARTNERS L P/IL | Beneficial Owner (10% or more) | Purchase | Jun 19, 2017 | 1,109,258 |
| CARRUTHERS R MICHAEL | Officer | Purchase | Dec 1, 2016 | 24,000 |
| CONGLETON JON | Officer | Purchase | Jun 15, 2016 | 20,000 |
| CONWAY ROBERT E | Director | Purchase | May 8, 2017 | 45,000 |
| RODMAN DAVID MALCOM | Officer | Automatic Sale | Jan 3, 2017 | 11,368 |
| TROHA JANICE | Officer | Purchase | May 4, 2017 | 10,000 |